Non-isotopic method for quantitation of platelets and erythrocytes in experimental thrombi

Thrombosis and Haemostasis

Volumn 75, Issue 4, 1996, Pages 668-673

  Dale, George L ^a,b   Hynes, Laurie A ^a   Wolf, Roman F ^a   Williams, Laura S ^a   Burstein, Samuel A ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CHYMOTRYPSIN; HEMOGLOBIN; THROMBOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOVENOUS SHUNT; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE COUNT; EXPERIMENTAL MODEL; FLOW CYTOMETRY; HYDROLYSIS; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOGENESIS; THROMBOSIS;

ANIMALS; BLOTTING, WESTERN; CHYMOTRYPSIN; DISEASE MODELS, ANIMAL; DOGS; ERYTHROCYTE COUNT; FLOW CYTOMETRY; HYDROLYSIS; PLATELET COUNT; THROMBOSIS;

EID: 0029870053     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Didisheim P. Animal models useful in the study of thrombosis and antithrombotic agents. Prog Hemostas Thromb 1972; 1: 165-97.
2. Cadroy Y, Horbett TA, Hanson SR. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo. J Lab Clin Med 1989; 113: 436-48.
3. Freund M, Mantz F, Nicolini P, Gachet C, Mulvihill J, Meyer L, Beretz A, Cazenave JP. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: A pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition. Thromb Haemost 1993; 69: 515-21.
4. Schaffer LW, Davidson JT, Siegl PKS, Gould RJ, Nutt RF, Brady SF, Connolly TM. Recombinant leech antiplatelet protein prevents collagen-mediated platelet aggregation but not collagen graft thrombosis in baboons. Arteriosclerosis Thromb 1993; 13: 1593-1601.
5. Ip WF, Zingg W, Sefton MV. Parallel flow arteriovenous shunt for the ex vivo evaluation of heparinized materials. J Biomedical Materials Res 1985; 19: 161-78.
6. Vogel GMT, van Amsterdam RGM, Kop WJ, Meuleman DG. Pentasaccharide and Orgaran arrest, whereas heparin delays thrombus formation in a rat arteriovenous shunt. Thromb Haemost 1993; 69: 29-34.
7. Peters RF, Lees CM, Mitchell KA, Tweed MF, Talbot MD, Wallis RB. The characterization of thrombus development in an improved model of arterio-venous shunt thrombosis in the rat and the effects of recombinant desulphatohirudin (CPG 39393), heparin and iloprost. Thromb Haemost 1991; 65: 268-74.
8. Harker LA, Kelly AB, Hanson SR. Experimental arterial thrombosis in nonhuman primates. Circulation 1991; 83: IV-41-IV-55.
9. Collen D, Lu HR, Stassen J-M, Vreys I, Yasuda T, Bunting S, Gold HK. Antithrombotic effects and bleeding time prolongation with synthetic platelet GPIIb/IIIa inhibitors in animal models of platelet-mediated thrombosis. Thromb Haemost 1994; 71: 95-102.
10. Somers D, Kinlough-Rathbone RL, Richardson M, Mustard JF. The relation among vessel injury, thrombus formation and platelet survival in rabbits. Exp Mol Pathol 1990; 53: 239-54.
11. Yao SK, Ober JC, Garfinkel LI, Hagay Y, Ezov N, Ferguson JJ, Anderson HV, Panel A, Gorecki M, Buja LM, Willerson JT. Blockade of platelet membrane glycoprotein Ib receptors delays intracoronary thrombogenesis, enhances thrombolysis, and delays coronary artery reocclusion in dogs. Circulation 1994; 89: 2822-8.
12. Lundell A, Bergqvist D, Lindblad B. The uptake of platelets, fibrinogen and leukocytes in ePTFE vascular grafts in relation to blood flow. An experimental study in sheep. Eur J Vasc Surg 1993; 7: 698-703.
13. Mulvihill JN, Huisman HG, Cazenave JP, van Mourik JA, van Aken WG. The use of monoclonal antibodies to human platelet membrane glycoprotein IIb-IIIa to quantitate platelet deposition on artificial surfaces. Thromb Haemost 1987; 58: 724-31.
14. Burstein SA, Friese P, Downs T, Epstein RE. Canine megakaryocytopoiesis: Analysis utilizing a monoclonal antibody to a 140 kD dog platelet protein. Exp Hematol 1991; 19: 47-52.
15. Heilmann E, Hynes LA, Friese P, George JN, Burstein SA, Dale GL. Dog platelets accumulate intracellular fibrinogen as they age. J Cell Physiol 1994; 161: 23-30.
16. McCoy TJ, Wabers HD, Cooper SL. Series shunt evaluation of polyurethane vascular graft materials in chronically A-V shunted canines. J Biomedical Materials Res 1990; 24: 107-29.
17. Fox JEB, Taylor RG, Taffarel M, Boyles JK, Goll DE. Evidence that activation of platelet calpain is induced as a consequence of binding of adhesive ligand to the integrin, glycoprotein IIb-IIIa. J Cell Biol 1993; 120: 1501-7.
18. Clagett GP, Hufnagel H, Watkins MT, Sharefkin JB. Platelet survival and serotonin content after placement of arterial prostheses in dogs: Effects of neointimal coverage and high- and low-dose aspirin J Vasc Surg 1987; 6: 555-62.
19. Bachmann F. The plasminogen-plasmin enzyme system. In: Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Colman RW, Hirsh J, Marder VJ, Salzman EW. eds. Lippincott, Philadelphia, 1994; Ed. 3rd pp 1592-1622